Mohammed Sikander

710 total citations
23 papers, 562 citations indexed

About

Mohammed Sikander is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Mohammed Sikander has authored 23 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Genetics. Recurrent topics in Mohammed Sikander's work include Glycosylation and Glycoproteins Research (5 papers), Advances in Cucurbitaceae Research (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Mohammed Sikander is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Advances in Cucurbitaceae Research (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Mohammed Sikander collaborates with scholars based in United States, India and Saudi Arabia. Mohammed Sikander's co-authors include Subhash C. Chauhan, Murali M. Yallapu, Meena Jaggi, Sheema Khan, Neeraj Chauhan, Nadeem Zafar, Sonam Kumari, Mohd Saif Zaman, Shabnam Malik and Bilal Bin Hafeez and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Mohammed Sikander

22 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammed Sikander United States 12 347 141 133 90 85 23 562
Lixia Pei China 15 311 0.9× 46 0.3× 82 0.6× 55 0.6× 52 0.6× 27 691
Kai Dong China 15 176 0.5× 75 0.5× 57 0.4× 89 1.0× 77 0.9× 32 527
Samil Jung South Korea 17 497 1.4× 83 0.6× 88 0.7× 33 0.4× 66 0.8× 34 877
Michael Yuan‐Chien Chen Taiwan 13 281 0.8× 55 0.4× 75 0.6× 66 0.7× 56 0.7× 23 569
Saba Hajazimian Iran 15 217 0.6× 87 0.6× 99 0.7× 36 0.4× 25 0.3× 27 489
Rama P. Ramanujam United States 13 456 1.3× 200 1.4× 350 2.6× 102 1.1× 32 0.4× 20 890
Peter H. Killian Germany 7 335 1.0× 134 1.0× 92 0.7× 216 2.4× 36 0.4× 9 569
Ting Tao China 11 375 1.1× 140 1.0× 129 1.0× 22 0.2× 52 0.6× 15 609
Wanle Hu China 15 219 0.6× 76 0.5× 149 1.1× 43 0.5× 42 0.5× 22 508

Countries citing papers authored by Mohammed Sikander

Since Specialization
Citations

This map shows the geographic impact of Mohammed Sikander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Sikander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Sikander more than expected).

Fields of papers citing papers by Mohammed Sikander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed Sikander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Sikander. The network helps show where Mohammed Sikander may publish in the future.

Co-authorship network of co-authors of Mohammed Sikander

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed Sikander. A scholar is included among the top collaborators of Mohammed Sikander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed Sikander. Mohammed Sikander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wahid, Mohd, et al.. (2025). Safety and Efficacy of Repurposed Smallpox Vaccines Against Mpox: A Critical Review of ACAM2000, JYNNEOS, and LC16. Journal of Epidemiology and Global Health. 15(1). 88–88. 3 indexed citations
2.
Malik, Shabnam, Mohammed Sikander, Mohd Wahid, et al.. (2024). Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance. Cancer and Metastasis Reviews. 43(3). 981–999. 5 indexed citations
3.
4.
Malik, Shabnam, et al.. (2024). Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy. Journal of Ovarian Research. 17(1). 161–161. 3 indexed citations
5.
Gupta, Meenakshi, Tanveer Naved, Archana Sharma, et al.. (2023). Pharmacognostical and Phytochemical Evaluation of a Unani Polyherbal Formulation: Dawa ul Kurkum by HPTLC. Separations. 10(2). 89–89. 4 indexed citations
6.
Sikander, Mohammed, Shabnam Malik, Sonam Kumari, et al.. (2023). Synthesis and Antitumor Activity of Brominated-Ormeloxifene (Br-ORM) against Cervical Cancer. ACS Omega. 8(42). 38839–38848. 1 indexed citations
7.
Hatami, Elham, Prashanth K.B. Nagesh, Mohammed Sikander, et al.. (2022). Tannic Acid Exhibits Antiangiogenesis Activity in Nonsmall-Cell Lung Cancer Cells. ACS Omega. 7(27). 23939–23949. 16 indexed citations
8.
Chaib, Mehdi, Bilal Bin Hafeez, Deidre Daria, et al.. (2022). Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. Communications Biology. 5(1). 1181–1181. 12 indexed citations
9.
Kashyap, Vivek K., Neeraj Chauhan, Anupam Dhasmana, et al.. (2022). Abstract 305: Novel nanoformulation of piperlongumine for pancreatic cancer therapy. Cancer Research. 82(12_Supplement). 305–305. 1 indexed citations
10.
Kumari, Sonam, Mohammed Sikander, Shabnam Malik, et al.. (2021). Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells. Biomedicines. 9(12). 1814–1814. 6 indexed citations
11.
Sikander, Mohammed, Shabnam Malik, Murali M. Yallapu, et al.. (2020). Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction. Molecules. 25(24). 5905–5905. 14 indexed citations
12.
Massey, Andrew E., Mohammed Sikander, Neeraj Chauhan, et al.. (2019). Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. Nanomedicine Nanotechnology Biology and Medicine. 20. 102027–102027. 25 indexed citations
13.
Chauhan, Neeraj, Murali M. Yallapu, Diane M. Maher, et al.. (2019). Abstract 3636: Generation of polymeric nanoformulation of ormeloxifene for cervical cancer treatment. Cancer Research. 79(13_Supplement). 3636–3636. 1 indexed citations
14.
Sikander, Mohammed, Shabnam Malik, Sheema Khan, et al.. (2019). Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer). Cells. 9(1). 103–103. 27 indexed citations
15.
Hafeez, Bilal Bin, Aditya Ganju, Mohammed Sikander, et al.. (2017). Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression. Molecular Cancer Therapeutics. 16(10). 2267–2280. 43 indexed citations
16.
Khan, Sheema, Mohammed Sikander, Mara C. Ebeling, et al.. (2016). MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression. Oncogene. 36(4). 491–500. 26 indexed citations
17.
Setua, Saini, Sheema Khan, Murali M. Yallapu, et al.. (2016). Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy. Journal of Gastrointestinal Surgery. 21(1). 94–105. 37 indexed citations
18.
Sikander, Mohammed, Bilal Bin Hafeez, Shabnam Malik, et al.. (2016). Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer. Scientific Reports. 6(1). 36594–36594. 64 indexed citations
19.
Zaman, Mohd Saif, Neeraj Chauhan, Murali M. Yallapu, et al.. (2016). Curcumin Nanoformulation for Cervical Cancer Treatment. Scientific Reports. 6(1). 20051–20051. 154 indexed citations
20.
Khan, Sheema, Mara C. Ebeling, Mohd Saif Zaman, et al.. (2014). MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer. Oncotarget. 5(17). 7599–7609. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lixia Pei Breakdown of academic impact, for papers by Kai Dong Breakdown of academic impact, for papers by Samil Jung Breakdown of academic impact, for papers by Michael Yuan‐Chien Chen Breakdown of academic impact, for papers by Saba Hajazimian Breakdown of academic impact, for papers by Rama P. Ramanujam Breakdown of academic impact, for papers by Peter H. Killian Breakdown of academic impact, for papers by Ting Tao Breakdown of academic impact, for papers by Wanle Hu
Rankless by CCL
2026